Subthreshold Micropulse Laser Treatment of Acute Central Serous Chorioretinopathy

Subthreshold Micropulse 532nm Green Laser Treatment of Acute Central Serous Chorioretinopathy - GSML 523 nm treatment of Acute CSCR

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043234

Enrollment

Registered

2021-02-03

Start date

2015-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with any age, any sex suffering from acute type of CSCR. Exclusion criteria included any causes of drop of vision other than CSCR and patients who received any other form of treatment.

Interventions

green subthreshold micropulse laser

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Any age, any sex suffering from acute type of CSCR.

Exclusion criteria

Exclusion criteria: Exclusion criteria included any causes of drop of vision other than CSCR and patients who received any other form of treatment.

Design outcomes

Primary

Measure	Time frame
The mean base line best corrected visual acuity significantly improved after 18 months.	—

Secondary

Measure	Time frame
The mean central macular thickness show statistically significant reduction after 18 months of trestement	—

Countries

Africa

Contacts

Public Contactheba Attallah

Minis University Hospital Heba Radi Attallah

hebaradi1974@gmail.com01002554107

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026